Literature DB >> 19882716

Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment.

Victoria E Shaw1, Sharon Spana, Keyoumars Ashkan, Alim-Louis Benabid, Jonathan Stone, Gary E Baker, John Mitrofanis.   

Abstract

This study explores whether near-infrared (NIr) light treatment neuroprotects dopaminergic cells in the substantia nigra pars compacta (SNc) and the zona incerta-hypothalamus (ZI-Hyp) from degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. BALB/c albino mice were divided into four groups: 1) Saline, 2) Saline-NIr, 3) MPTP, 4) MPTP-NIr. The injections were intraperitoneal and they were followed immediately by NIr light treatment (or not). Two doses of MPTP, mild (50 mg/kg) and strong (100 mg/kg), were used. Mice were perfused transcardially with aldehyde fixative 6 days after their MPTP treatment. Brains were processed for tyrosine hydroxylase (TH) immunochemistry. The number of TH(+) cells was estimated using the optical fractionator method. Our major finding was that in the SNc there were significantly more dopaminergic cells in the MPTP-NIr compared to the MPTP group (35%-45%). By contrast, in the ZI-Hyp there was no significant difference in the numbers of cells in these two groups. In addition, our results indicated that survival in the two regions after MPTP insult was dose-dependent. In the stronger MPTP regime, the magnitude of loss was similar in the two regions ( approximately 60%), while in the milder regime cell loss was greater in the SNc (45%) than ZI-Hyp ( approximately 30%). In summary, our results indicate that NIr light treatment offers neuroprotection against MPTP toxicity for dopaminergic cells in the SNc, but not in the ZI-Hyp.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19882716     DOI: 10.1002/cne.22207

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  34 in total

Review 1.  Transcranial near-infrared laser therapy applied to promote clinical recovery in acute and chronic neurodegenerative diseases.

Authors:  Paul A Lapchak
Journal:  Expert Rev Med Devices       Date:  2012-01       Impact factor: 3.166

2.  Is it time to consider photobiomodulation as a drug equivalent?

Authors:  Tiina Karu
Journal:  Photomed Laser Surg       Date:  2013-04-19       Impact factor: 2.796

Review 3.  Brain Photobiomodulation Therapy: a Narrative Review.

Authors:  Farzad Salehpour; Javad Mahmoudi; Farzin Kamari; Saeed Sadigh-Eteghad; Seyed Hossein Rasta; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

Review 4.  Low-level light therapy of the eye and brain.

Authors:  Julio C Rojas; F Gonzalez-Lima
Journal:  Eye Brain       Date:  2011-10-14

5.  Photobiomodulation-induced changes in a monkey model of Parkinson's disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatum.

Authors:  Nabil El Massri; Ana P Lemgruber; Isobel J Rowe; Cécile Moro; Napoleon Torres; Florian Reinhart; Claude Chabrol; Alim-Louis Benabid; John Mitrofanis
Journal:  Exp Brain Res       Date:  2017-03-15       Impact factor: 1.972

6.  Near infrared (NIr) light increases expression of a marker of mitochondrial function in the mouse vestibular sensory epithelium.

Authors:  Lucy Zhang; Victoria W K Tung; Miranda Mathews; Aaron J Camp
Journal:  J Vis Exp       Date:  2015-03-14       Impact factor: 1.355

7.  No evidence for toxicity after long-term photobiomodulation in normal non-human primates.

Authors:  Cécile Moro; Napoleon Torres; Katerina Arvanitakis; Karen Cullen; Claude Chabrol; Diane Agay; Fannie Darlot; Alim-Louis Benabid; John Mitrofanis
Journal:  Exp Brain Res       Date:  2017-07-25       Impact factor: 1.972

8.  The time course of action of two neuroprotectants, dietary saffron and photobiomodulation, assessed in the rat retina.

Authors:  Fabiana Di Marco; Stefania Romeo; Charith Nandasena; Sivaraman Purushothuman; Charean Adams; Silvia Bisti; Jonathan Stone
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

9.  Gene and noncoding RNA regulation underlying photoreceptor protection: microarray study of dietary antioxidant saffron and photobiomodulation in rat retina.

Authors:  Riccardo Natoli; Yuan Zhu; Krisztina Valter; Silvia Bisti; Janis Eells; Jonathan Stone
Journal:  Mol Vis       Date:  2010-09-03       Impact factor: 2.367

10.  Evidence for encephalopsin immunoreactivity in interneurones and striosomes of the monkey striatum.

Authors:  Nabil El Massri; Karen M Cullen; Sebastian Stefani; Cécile Moro; Napoleon Torres; Alim-Louis Benabid; John Mitrofanis
Journal:  Exp Brain Res       Date:  2018-01-29       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.